Age-Related Macular Degeneration (AMD) Treatment in Singapore

AMD is a progressive eye condition affecting central vision, most commonly in adults over 50. It does not cause complete blindness but can make everyday tasks such as reading, driving, and recognising faces increasingly difficult. While there is currently no cure for AMD, early diagnosis and appropriate management can help slow progression and protect the vision you have.

At Asia Pacific Eye Centre, our retinal specialist offers assessments and specialist-led care for macular degeneration in Singapore, covering both dry and wet AMD.

What Is Age-Related Macular Degeneration?

The macula is the small central area of the retina responsible for sharp, detailed vision. It is what allows you to read text, recognise faces, and see fine detail clearly.

Age-related macular degeneration (AMD) is a chronic eye condition that damages the macula, causing central vision to become blurred, distorted, or gradually lost over time.

AMD does not typically affect peripheral (side) vision, which means most people retain the ability to navigate their environment. However, the loss of central vision can make tasks such as reading, driving, and watching television progressively more difficult.
A specialist eye examination can detect the early signs of age-related macular degeneration, often before a patient notices any change in their vision
AMD is a major cause of vision loss in adults aged 50 and above. It tends to develop gradually, and many people are unaware of early changes until the condition has advanced.

What Is the Difference Between Dry and Wet AMD?

There are two forms of AMD. Understanding the difference matters because their progression and management differ significantly.
Dry AMD Wet AMD
How common More common; affects around 4 in 5 people with AMD Affects around 10–15% of people with AMD
How it develops Light-sensitive cells in the macula gradually break down over time Abnormal blood vessels grow beneath the retina and leak fluid, blood, or protein
Speed of progression Usually slow and gradual Can progress rapidly, sometimes within weeks
Vision impact Gradual loss of central vision Significant central vision loss if not treated promptly
Can it become wet AMD? Dry AMD can progress to wet AMD in some cases Wet AMD usually develops in people who already have dry AMD
Smoking risk Increased risk with smoking Smokers are approximately 4 times more likely to develop wet AMD

What Are the Symptoms of Age-Related Macular Degeneration?

AMD can develop gradually without causing pain or obvious discomfort, which is why it is often not noticed until vision changes become significant. Symptoms may affect one or both eyes and can vary between individuals.
Common signs of AMD include:

When Should You Seek Prompt Eye Assessment?

Some symptoms warrant an urgent review rather than a routine appointment. You should seek prompt assessment if you notice:
A sudden or rapid change in your central vision
A new dark patch or blank area appearing in your vision
A sudden increase in visual distortion, particularly in one eye

What Causes Age-Related Macular Degeneration?

The exact cause of AMD is not fully understood. It is thought to involve a combination of ageing, genetics, and lifestyle factors, including smoking, hypertension, cardiovascular disease, and obesity. Some risk factors can be modified; others cannot.

Modifiable Risk Factors

Non-Modifiable Risk Factors

Preventing Macular Degeneration

While AMD cannot be completely prevented, certain lifestyle adjustments may help reduce your risk or slow its progression:

How Is Macular Degeneration Diagnosed?

If you have noticed changes to your central vision, or if you have risk factors that make AMD more likely, a formal eye assessment is the right next step. A diagnosis of AMD is made through a comprehensive eye assessment. At APEC, this typically involves:

What to Expect After Your Assessment

Receiving a diagnosis of AMD can feel unsettling, and it is natural to have questions about macular degeneration treatment and what to expect next.

Your care at APEC will involve regular monitoring appointments, and your specialist will explain what changes to watch for between visits.
For dry AMD, the focus is on preserving your current vision and catching any progression early.
For wet AMD, treatment typically begins promptly, with follow-up intervals adjusted based on your response.

What Macular Degeneration Treatments Are Available?

Management of Dry Age-Related Macular Degeneration

There is currently no treatment that reverses dry AMD. Management focuses on monitoring the condition closely and reducing the risk of progression. For patients with intermediate or advanced dry AMD, your specialist may recommend:

Treatment for Wet Age-Related Macular Degeneration

Wet AMD is treated primarily with anti-VEGF (anti-vascular endothelial growth factor) injections. These are administered directly into the eye under local anaesthetic and work by inhibiting the growth of the abnormal blood vessels responsible for leakage and scarring.

Anti-VEGF therapy does not restore vision that has already been lost, but in many patients it can stabilise the condition and, in some cases, may lead to partial improvement. The frequency of injections varies by individual and is determined by your specialist based on how your eye responds to treatment.

Treatment is typically ongoing, and regular follow-up is important to assess response and adjust the schedule accordingly.

Age-Related Macular Degeneration Screening at APEC

Whether you are experiencing symptoms or simply want to understand your baseline eye health, AMD screening at APEC is a practical first step. If you are over 50, have a family history of AMD, or have noticed any changes to your central vision, an assessment is advisable.

Cataract / Glaucoma / Age-Related Macular Degeneration Screening

Cataract/Glaucoma/Age-Related Macular Degeneration Screening

$ 200
(Exclusive GST)
  •  
$ 218
(Inclusive GST)
  •  

Frequently Asked Questions About Macular Degeneration

There is currently no cure for AMD. However, for wet AMD,Ā anti-VEGF treatment can slow or stabilise progression in many patients. For dry AMD, management focuses on monitoring and reducing the risk of progression. Early detection remains the most effective way to protect your vision.

Treatment for wet AMD may lead to partial improvement in some patients, but it is primarily aimed at stabilising the condition rather than restoring lost vision. Vision that has already been lost due to AMD is generally not recoverable. This is why early assessment matters.

Dry AMD involves the gradual breakdown of light-sensitive cells in the macula over time. Wet AMD involves abnormal blood vessel growth beneath the retina, which can cause rapid vision loss if left untreated. Wet AMD usually develops in people who already have dry AMD.

Wet AMD can progress significantly within weeks if untreated. Any sudden change in central vision should be assessed promptly rather than monitored at home.

Diagnosis involves a comprehensive eye assessment, including visual acuity testing, dilated examination, OCT imaging, and retinal photography. In some cases, fluorescein angiography may be used to assess blood vessel activity.

This varies by patient and by the specific medication used. Initially, injections may be given monthly. Over time, the interval may be extended depending on how your eye responds. Your specialist will determine the schedule most appropriate for you.

Yes. AMD can affect one or both eyes. Your specialist will monitor both eyes at each assessment.

You should seek assessment if you notice blurring, distortion, or missing areas in your central vision, even if the change seems minor. For sudden or rapid changes, seek an appointment as soon as possible rather than waiting for a routine visit.

Dr Wong Chee Wai, retinal specialist and Senior Consultant Eye Surgeon at Asia Pacific Eye Centre

Our Retinal Specialist

Dr. Wong Chee Wai

MBBS (Singapore), M.Med (Ophth), FAMS (Ophth), MCI (Singapore), PhD (Utrecht)
Senior Consultant and Eye Surgeon | Sub-specialties: Retinal Conditions, Cataracts
Languages: English, Mandarin, Cantonese

Dr Wong Chee Wai is a fellowship-trained retinal specialist with expertise in both medical and surgical retina. He completed his Vitreoretinal subspecialty fellowship training at the Singapore National Eye Centre (SNEC), and went on to found the Surgical Retina Service at Sengkang Hospital.

A former consultant and deputy director of undergraduate education at SNEC, Dr Wong has published more than 60 research articles in the field of retinal conditions and ocular drug delivery, and holds a PhD from Utrecht University. He was recognised as the top candidate in the Specialist Exit Examination in Ophthalmology, receiving three gold medals, and has been awarded a Research Training Fellowship by the National Medical Research Council (2017).

Dr Wong sees patients with a wide range of retinal conditions, including age-related macular degeneration.

Book a Consultation

Get an eye checkup with us now!

Interested in speaking with our retinal specialist? Get in touch with us to arrange your consultation.

Book a Consultation

Get an eye checkup with us now!

Interested to fix a consult with our eye specialist? Get in touch with us!